Band vs ring surgery for tricuspid valve leakage
Part of Heart & circulation clinical trials.
This trial compares two surgical options (a band versus a ring) to treat tricuspid valve regurgitation, which means blood leaks backward through the tricuspid valve. It may help your heart work more efficiently and reduce symptoms by testing which device works better for people with the right valve problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 70 years old when you consent
- You can (or your legal representative can) give written informed consent
- Your heart ultrasound (echocardiogram) shows tricuspid valve leakage that qualifies for the study
- Your leakage is not mild (you likely need moderate or worse, as decided by the study checks)
- You have not had prior tricuspid valve leaflet surgery or any implanted tricuspid valve device
- You do not have certain major heart or medical conditions that limit survival or make surgery unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a minimally invasive “clip” procedure can safely improve tricuspid valve leakage (a heart valve that doesn’t close tightly). It focuses on older adults who are considered too high-risk for open-heart surgery and still have enough heart pumping strength to benefit.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
This trial studies whether a heart procedure called K-Clip TM helps people with severe “secondary” tricuspid valve leakage who are at high risk for open-heart surgery. It aims to improve symptoms and valve function using a less-invasive, catheter-based repair.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.